PATENT CLAIM ANALYSIS

Application Number: 15745217
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "013300"]

Abstract:
The present invention relates to a novel polypeptide having chemokine activity and, more specifically, to a polypeptide composed of the amino acid sequence represented by SEQ ID NO: 1 and a use thereof. The polypeptide of the present invention is composed of SEQ ID NO: 1 and exhibits chemokine activity through the binding with CCR3, and thus, the polypeptide has a high utilization effect for various purposes, such as immunoregulation, and diagnosis, treatment, and medicine development for CCR3-mediated diseases or disease symptoms.

Claim (Index 23):
The method of  claim 20 , wherein the CCR3-mediated disease is selected from the group consisting of asthma, allergic rhinitis, hypersensitive lung disease, hypersensitivity pneumonia, eosinophilic pneumonia, respiratory allergic disease, inflammatory bowel disease, psoriasis, dermatitis, eczema, inflammatory skin disease, a kidney cancer and a prostate cancer.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 86.0
- Lexical Diversity: 1.64912
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['11216610', '15639434', '10283028', '10260270', '15629700']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7551846790859977
- 35 USC 102 Novelty (BERT): 0.5122251678515378
- Combined Prediction Score: 0.7308887279625518
- Mean Citation Score: 219.21281800000003
- Max Citation Score: 232.83298
- Similarity Product: 145.61384441402197

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test